Cited by 614Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchParkinson's Disease Mechanisms and Treatments

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum

Open access
Valjent, Emmanuel, Pascoli, Vincent, Svenningsson, Per, Paul, Surojit, Enslen, Hervé, Corvol, Jean-Christophe, Stipanovich, Alexandre, Caboche, Jocelyne +5 more·2005·Proceedings of the National Academy of Sciences

Abstract

Many drugs of abuse exert their addictive effects by increasing extracellular dopamine in the nucleus accumbens, where they likely alter the plasticity of corticostriatal glutamatergic transmission. This mechanism implies key molecular alterations in neurons in which both dopamine and glutamate inputs are activated. Extracellular signal-regulated kinase (ERK), an enzyme important for long-term synaptic plasticity, is a good candidate for playing such a role. Here, we show in mouse that d -amphetamine activates ERK in a subset of medium-size spiny neurons of the dorsal striatum and nucleus accumbens, through the combined action of glutamate NMDA and D1-dopamine receptors. Activation of ERK by d -amphetamine or by widely abused drugs, including cocaine, nicotine, morphine, and Δ 9 -tetrahydrocannabinol was absent in mice lacking dopamine- and cAMP-regulated phosphoprotein of M r 32,000 (DARPP-32). The effects of d -amphetamine or cocaine on ERK activation in the striatum, but not in the prefrontal cortex, were prevented by point mutation of Thr-34, a DARPP-32 residue specifically involved in protein phosphatase-1 inhibition. Regulation by DARPP-32 occurred both upstream of ERK and at the level of striatal-enriched tyrosine phosphatase (STEP). Blockade of the ERK pathway or mutation of DARPP-32 altered locomotor sensitization induced by a single injection of psychostimulants, demonstrating the functional relevance of this regulation. Thus, activation of ERK, by a multilevel protein phosphatase-controlled mechanism, functions as a detector of coincidence of dopamine and glutamate signals converging on medium-size striatal neurons and is critical for long-lasting effects of drugs of abuse.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0408305102

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [1]Di Chiara, G. (1999) Eur. J. Pharmacol. 375, 13-30. [DOI] [PubMed] [Google Scholar]
  2. [2]Schultz, W. (2002) Neuron 36, 241-263. [DOI] [PubMed] [Google Scholar]
  3. [3]Reynolds, J. N. J. & Wickens, J. R. (2002) Neural Netw. 15, 507-521. [DOI] [PubMed] [Google Scholar]
  4. [4]Hyman, S. E. & Malenka, R. C. (2001) Nat. Rev. Neurosci. 2, 695-703. [DOI] [PubMed] [Google Scholar]
  5. [5]Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R. & Caboche, J. (2000) J. Neurosci. 20, 8701-8709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. [6]Thomas, G. M. & Huganir, R. L. (2004) Nat. Rev. Neurosci. 5, 173-183. [DOI] [PubMed] [Google Scholar]
  7. [7]Valjent, E., Pages, C., Rogard, M., Besson, M. J., Maldonado, R. & Caboche, J. (2001) Eur. J. Neurosci. 14, 342-352. [DOI] [PubMed] [Google Scholar]
  8. [8]Drago, J., Gerfen, C. R., Lachowicz, J. E., Steiner, H., Hollon, T. R., Love, P. E., Ooi, G. T., Grinberg, A., Lee, E. J., Huang, S. P., et al. (1994) Proc. Natl. Acad. Sci. USA 91, 12564-12568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. [9]Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., Cheramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) Science 281, 838-842. [DOI] [PubMed] [Google Scholar]
  10. [10]Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G. & Greengard, P. (2003) Science 302, 1412-1415. [DOI] [PubMed] [Google Scholar]
  11. [11]Valjent, E., Pages, C., Hervé, D., Girault, J. A. & Caboche, J. (2004) Eur. J. Neurosci. 19, 1826-1836. [DOI] [PubMed] [Google Scholar]
  12. [12]Ouimet, C. C., Miller, P. E., Hemmings, H. C., Jr., Walaas, S. I. & Greengard, P. (1984) J. Neurosci. 4, 111-124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. [13]Lombroso, P. J., Naegele, J. R., Sharma, E. & Lerner, M. (1993) J. Neurosci. 13, 3064-3074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. [14]Hervé, D., Lévi-Strauss, M., Marey-Semper, I., Verney, C., Tassin, J.-P., Glowinski, J. & Girault, J. A. (1993) J. Neurosci. 13, 2237-2248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. [15]Kawaguchi, Y. (1997) Neurosci. Res. 27, 1-8. [DOI] [PubMed] [Google Scholar]
  16. [16]Snyder, G. L., Allen, P. B., Fienberg, A. A., Valle, C. G., Huganir, R. L., Nairn, A. C. & Greengard, P. (2000) J. Neurosci. 20, 4480-4488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. [17]Svenningsson, P., Nishi, A., Fisone, G., Girault, J. A., Nairn, A. C. & Greengard, P. (2004) Annu. Rev. Pharmacol. Toxicol. 44, 269-296. [DOI] [PubMed] [Google Scholar]
  18. [18]Gustafson, E. L., Girault, J. A., Hemmings, H. C., Jr., Nairn, A. C. & Greengard, P. (1991) J. Comp. Neurol. 310, 170-188. [DOI] [PubMed] [Google Scholar]
  19. [19]Desdouits, F., Cheetham, J. J., Huang, H. B., Kwon, Y. G., da Cruz e Silva, E. F., Denefle, P., Ehrlich, M. E., Nairn, A. C., Greengard, P. & Girault, J. A. (1995) Biochem. Biophys. Res. Commun. 206, 652-658. [DOI] [PubMed] [Google Scholar]
  20. [20]Hemmings, H. C., Jr., Nairn, A. C., Elliott, J. I. & Greengard, P. (1990) J. Biol. Chem. 265, 20369-20376. [PubMed] [Google Scholar]
  21. [21]Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L. H., Kwon, Y. T., Girault, J. A., Czernik, A. J., et al. (1999) Nature 402, 669-671. [DOI] [PubMed] [Google Scholar]
  22. [22]Sweatt, J. D. (2001) J. Neurochem. 76, 1-10. [DOI] [PubMed] [Google Scholar]
  23. [23]Konradi, C., Cole, R. L., Heckers, S. & Hyman, S. E. (1994) J. Neurosci. 14, 5623-5634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. [24]Atkins, C. M., Selcher, J. C., Petraitis, J. J., Trzaskos, J. M. & Sweatt, J. D. (1998) Nat. Neurosci. 1, 602-609. [DOI] [PubMed] [Google Scholar]
  25. [25]Vanderschuren, L. J., Schmidt, E. D., De Vries, T. J., Van Moorsel, C. A., Tilders, F. J. & Schoffelmeer, A. N. (1999) J. Neurosci. 19, 9579-9586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. [26]Zhou, B., Wang, Z. X., Zhao, Y., Brautigan, D. L. & Zhang, Z. Y. (2002) J. Biol. Chem. 277, 31818-31825. [DOI] [PubMed] [Google Scholar]
  27. [27]Paul, S., Nairn, A. C., Wang, P. & Lombroso, P. J. (2003) Nat. Neurosci. 6, 34-42. [DOI] [PubMed] [Google Scholar]
  28. [28]Pulido, R., Zuniga, A. & Ullrich, A. (1998) EMBO J. 17, 7337-7350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. [29]Nika, K., Hyunh, H., Williams, S., Paul, S., Bottini, N., Tasken, K., Lombroso, P. J. & Mustelin, T. (2004) Biochem. J. 378, 335-342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. [30]Sgambato, V., Pagès, C., Rogard, M., Besson, M. J. & Caboche, J. (1998) J. Neurosci. 18, 8814-8825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. [31]Vanhoutte, P., Barnier, J. V., Guibert, B., Pagès, C., Besson, M. J., Hipskind, R. A. & Caboche, J. (1999) Mol. Cell. Biol. 19, 136-146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. [32]Schwarzschild, M. A., Cole, R. L., Meyers, M. A. & Hyman, S. E. (1999) J. Neurochem. 72, 2248-2255. [DOI] [PubMed] [Google Scholar]
  33. [33]Krapivinsky, G., Krapivinsky, L., Manasian, Y., Ivanov, A., Tyzio, R., Pellegrino, C., Ben-Ari, Y., Clapham, D. E. & Medina, I. (2003) Neuron 40, 775-784. [DOI] [PubMed] [Google Scholar]
  34. [34]Kim, J. H., Liao, D., Lau, L. F. & Huganir, R. L. (1998) Neuron 20, 683-691. [DOI] [PubMed] [Google Scholar]
  35. [35]Chen, H. J., Rojas-Soto, M., Oguni, A. & Kennedy, M. B. (1998) Neuron 20, 895-904. [DOI] [PubMed] [Google Scholar]
  36. [36]Valjent, E., Hervé, D., Caboche, J. & Girault, J. A. (2003) Curr. Neuropharmacol. 1, 165-174. [Google Scholar]
  37. [37]Nestler, E. J. (2001) Nat. Rev. Neurosci. 2, 119-128. [DOI] [PubMed] [Google Scholar]
  38. [38]Buchwalter, G., Gross, C. & Wasylyk, B. (2004) Gene 324, 1-14. [DOI] [PubMed] [Google Scholar]
  39. [39]Gerfen, C. R., Miyachi, S., Paletzki, R. & Brown, P. (2002) J. Neurosci. 22, 5042-5054. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., Greengard, P., Hervé, D., & Girault, J.-A.
Affiliations
Inserm (FR)
Venue
Proceedings of the National Academy of Sciences
Published
2004-12-17
Volume
102
Issue
2
Pages
491-496
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2159891593
Cited by
614
References
40
Citations by year
2026: 1 · 2025: 9 · 2024: 15 · 2023: 15 · 2022: 20 · 2021: 26 · 2020: 25 · 2019: 22 · 2018: 18 · 2017: 26 · 2016: 23 · 2015: 33 · 2014: 38 · 2013: 25 · 2012: 44
FWCI
11.17
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • National Institute of Mental Health (MH40899, R01MH052711, P01MH040899, K02MH001527)
  • National Institute on Drug Abuse (DA10044, P01DA010044)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
ERK activation, DARPP-32, protein phosphatase 1, NMDA receptor, dopamine D1 receptor, nucleus accumbens, dorsal striatum, medium spiny neurons, cocaine, amphetamine, locomotor sensitization, drug addiction, synaptic plasticity, psychostimulants
MeSH terms
Animals, Cocaine, Corpus Striatum, Dextroamphetamine, Dopamine, Enzyme Activation, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Phosphoproteins, Phosphorylation, Signal Transduction, Receptors, N-Methyl-D-Aspartate, Glutamic Acid, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Mice, Dopamine and cAMP-Regulated Phosphoprotein 32

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review